Effects of fetal thymus transplantation on defective cellular immunity.
D000666:Amphotericin B / Q000627:therapeutic use; D000914:Antibodies, Viral; D000917:Antibody Formation; D002179:Candidiasis, Cutaneous / Q000188:drug therapy / Q000209:etiology; D002648:Child; D003022:Clotrimazole / Q000627:therapeutic use; D005333:Fetus; D006562:Herpes Zoster / Q000209:etiology; D006648:Histocompatibility; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007104:Immune Adherence Reaction; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000628:therapy*; D008213:Lymphocyte Activation; D008297:Male; D009109:Mumps virus / Q000276:immunology; D009578:Nitrobenzenes / Q000276:immunology; D012882:Skin Tests; D013936:Thymidine / Q000378:metabolism; D013950:Thymus Gland / Q000637:transplantation*; D014316:Tritium
D000914:Antibodies, Viral; D009578:Nitrobenzenes; D014316:Tritium; D000666:Amphotericin B; D003022:Clotrimazole; D013936:Thymidine